Expertise in
7
conditions

Fiona M. Miall

Leicester, ENG, GB 
Expertise in
7
conditions
Leicester, ENG, GB 

Overview

Fiona Miall practices practicing medicine in Leicester, United Kingdom.

Ms. Miall is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, and Classical Hodgkin Lymphoma.

She is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Leicester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study of Nivolumab Monotherapy in Patients With Relapsed/Refractory Hodgkin Lymphoma Fit for Autologous Stem Cell Transplant Who Fail to Reach Complete Metabolic Remission After First or Second Line Salvage Therapy
A Phase II Study of Nivolumab Monotherapy in Patients With Relapsed/Refractory Hodgkin Lymphoma Fit for Autologous Stem Cell Transplant Who Fail to Reach Complete Metabolic Remission After First or Second Line Salvage Therapy
Enrollment Status: Unknown
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drug: Nivolumab
Study Phase: Phase 2
AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Enrollment Status: Unknown
Publish Date: December 12, 2023
Intervention Type: Drug
Study Drug: Avelumab
Study Phase: Phase 2
View 1 Less Clinical Trial

27 Total Publications

Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.
Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.
Journal: British journal of haematology
Published: February 18, 2026

Frequently Asked Questions about Fiona M. Miall

Is Fiona M. Miall a top-rated expert for Non-Hodgkin Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Fiona M. Miall is classified as an Advanced expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fiona M. Miall participate in research or clinical trials?

Yes. Fiona M. Miall has published 27 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Fiona M. Miall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Miall's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile